iThriveMD Semaglutide Review
iThrive MD, ithrivemd.com
Also spelled as iThrive MD, ithrivemd.com — Same brand, same great service!
Our investigation of Compounded Semaglutide from iThriveMD
Semaglutide from $299, tirzepatide from $399 — billed every 28 days, so about 13 charges per year
Investigation Overview
The 28-Day Billing Cycle
iThriveMD states: "All memberships will be charged every 28 days from the start of the membership." That is not a month. A 28-day cycle produces 13.04 charges per year, not 12. On a $299 program, the difference between what a buyer assumes and what they pay is roughly $3,900 a year instead of $3,588 — about $312, or one extra charge annually. iThriveMD discloses this in its terms, which is more than a company hiding it would do. But it is disclosed in fine print while prices are presented in the way buyers instinctively read as monthly. Anyone comparing iThriveMD's $299 against a competitor's $299/month should compare $3,900 against $3,588.Published Pricing
- Semaglutide injections from $299
- Tirzepatide injections from $399
- Microdosing tirzepatide from $585, on a 12-month program paid in full — described as its lowest long-term tirzepatide pricing
- Member pricing across the wider menu once you start a weight-loss or hormone plan, with add-ons from $29
- A promotional $100 off applying to the first month only, not to package purchases
Compounding Disclosure Is Specific
iThriveMD states its medications are "physician-compounded under Section 503A in a USP-compliant sterile cleanroom." Naming the regulatory section and the cleanroom standard is more specific than most operators manage, though it stops short of the accreditation and release-testing detail published by Pure Pharmacy. Its risk disclosure is correctly worded: "Compounded drugs have not been reviewed or approved by the FDA for safety or effectiveness. Results have not been independently verified and may vary from person to person."Labs Before Treatment
iThriveMD requires "in-depth diagnostic testing and baseline labs before any plan begins," with a provider building a protocol around your goals, biology and bloodwork. It frames its offering around measuring and optimising "five systems that shape how you age," which is longevity-clinic positioning rather than strictly weight-loss care — and that framing carries the usual caveat that "optimisation" of biomarkers is not the same as demonstrated health benefit.Physical Clinics Plus Telehealth
In-person clinics operate throughout California and Arizona, with telehealth available across both states at the same member pricing. One published operational detail is a useful sign of real regulatory attention: "NAD+ injections are not eligible for shipment to Arizona. NAD+ wafers may be shipped to Arizona and California." Companies that track state-by-state shipping restrictions at product level are generally paying attention to the rules.What to Weigh
The microdosing tirzepatide program at $585 carries the same evidence problem as elsewhere in this comparison — sub-therapeutic dosing was not studied. The 12-month paid-in-full structure also means committing a substantial sum up front to a regimen with no trial behind it. And promotional urgency ("Ends Aug 31st") plus first-month-only discounts are standard pressure tactics. Geographically, this is a two-state operation.Our Investigation Summary
Our research (August 8, 2026) found iThriveMD operating longevity clinics across California and Arizona with telehealth in both states at the same member pricing, publishing compounded semaglutide from $299, tirzepatide from $399 and microdosing tirzepatide from $585 on a 12-month paid-in-full program. Its compounding disclosure is specific — "physician-compounded under Section 503A in a USP-compliant sterile cleanroom" — and its risk language is correctly worded, stating that compounded drugs have not been reviewed or approved by the FDA for safety or effectiveness. It requires in-depth diagnostic testing and baseline labs before any plan begins, which is a genuine clinical gate. The detail buyers most need to notice is the billing cycle: memberships are charged every 28 days, not monthly, which produces 13.04 charges a year rather than 12 — turning an apparent $299/month into roughly $3,900 annually instead of $3,588, an extra charge worth about $312. iThriveMD discloses this in its terms, but prices are presented in a way most buyers will read as monthly. Other cautions: the microdosing tirzepatide program uses sub-therapeutic doses no trial studied while requiring a 12-month payment up front; promotional urgency and first-month-only discounts are used; and coverage is limited to two states. A creditable operational sign is product-level state shipping compliance — NAD+ injections are stated as ineligible for shipment to Arizona while wafers are permitted.
How iThriveMD Works
Schedule a free consultation — all programs begin with one
Complete in-depth diagnostic testing and baseline labs before any plan begins
A provider builds a protocol around your goals, biology and bloodwork
Attend an in-person clinic in California or Arizona, or use telehealth in either state at the same member pricing
Medication is physician-compounded under Section 503A in a USP-compliant sterile cleanroom
Starting a weight-loss or hormone plan unlocks member pricing across the wider service menu
Memberships are charged every 28 days from your start date — 13 charges a year, not 12
What We Found
What's Good
- Publishes actual prices: semaglutide from $299, tirzepatide from $399
- In-person clinics throughout California and Arizona plus telehealth in both states
- Telehealth patients receive the same member pricing as in-clinic patients
- Requires in-depth diagnostic testing and baseline labs before any plan begins
- Specific compounding disclosure — Section 503A, USP-compliant sterile cleanroom
- Correctly worded FDA risk language on compounded medications
- Product-level state shipping compliance, e.g. NAD+ injection restrictions in Arizona
- Free initial consultation
- Member pricing across the wider menu with add-ons from $29
Watch Out For
- Bills every 28 days, not monthly — about 13 charges a year, so $299 becomes roughly $3,900 annually
- The 28-day cycle is disclosed only in terms while prices read as monthly
- Microdosing tirzepatide from $585 uses sub-therapeutic doses no trial studied
- The microdosing program requires 12 months paid in full up front
- Available only in California and Arizona
- Promotional urgency and first-month-only discounts used in marketing
- Longevity 'optimisation' framing is not the same as demonstrated health benefit
- No accreditation, third-party testing or beyond-use dating published
- Compounded medications are not FDA-approved for safety, effectiveness or quality
Pricing Breakdown
Safety & Medical Oversight
Customer Support
Key Features
Best For
California and Arizona patients who want lab-gated care with published prices and in-person options — provided they budget for 13 billing cycles a year rather than 12
Customer Reviews & Complaints
We assessed iThriveMD against its published material as of August 8, 2026.
What we verified directly: in-person clinics throughout California and Arizona with telehealth in both states; semaglutide injections from $299, tirzepatide from $399, microdosing tirzepatide from $585 on a 12-month paid-in-full program; add-ons from $29; a $100 first-month-only promotional discount excluded from package purchases; required in-depth diagnostic testing and baseline labs; physician compounding under Section 503A in a USP-compliant sterile cleanroom; NAD+ shipping restrictions specific to Arizona; and the statement that "all memberships will be charged every 28 days from the start of the membership."
The billing cycle is the finding a buyer most needs. A 28-day cycle yields 365 ÷ 28 = 13.04 charges annually. At $299 that is about $3,900 rather than the $3,588 a monthly reading implies — roughly one extra payment per year. iThriveMD does disclose it, and we credit that; but the disclosure sits in terms while the price is displayed the way buyers read as monthly, so the arithmetic is easy to miss.
The compounding language is better than average. Naming Section 503A and a USP-compliant sterile cleanroom is specific enough to be checkable, unlike the vague "accredited pharmacy" phrasing common elsewhere.
What we could not establish: which pharmacy compounds the medication, whether accreditation such as PCAB is held, third-party testing or beyond-use dating, founding year, refund and cancellation terms, or independent third-party review aggregates.
Is iThriveMD Legit?
"Is iThriveMD legitimate?" Our assessment as of August 8, 2026.
Official Verification: iThriveMD operates physical clinics across two states, requires baseline labs before treatment, publishes prices, and states its compounding pathway and facility standard specifically. Its product-level shipping restrictions — NAD+ injections not shippable to Arizona, wafers permitted — indicate a company tracking state pharmacy rules rather than ignoring them. We found no evidence of wrongdoing.
The 28-day cycle is a disclosure question, not a deception. The company states it in its terms. But a price displayed as $299 next to competitors' monthly figures invites a comparison that is off by an entire billing cycle each year. We flag it because it is exactly the kind of detail that costs real money quietly, and because a buyer who knows about it can simply factor it in.
Labs before treatment is the strongest clinical signal. Requiring diagnostic testing and baseline bloodwork before any plan begins puts iThriveMD ahead of the questionnaire-only tier of this market.
The microdosing program is where we would steer clear. Sub-therapeutic dosing has no trial evidence, and asking for twelve months paid in full converts an unstudied regimen into a large non-refundable-looking commitment. The standard-dose semaglutide and tirzepatide programs are the ones with evidence behind their active ingredients.
Red Flags Check:
- ✓ Physical clinics in California and Arizona plus telehealth
- ✓ Baseline labs and diagnostic testing required before any plan
- ✓ Prices published for the main programs
- ✓ Section 503A and USP-compliant cleanroom named specifically
- ✓ Correct FDA risk disclosure on compounded medication
- ✓ State-specific shipping restrictions observed at product level
- ⚠ 28-day billing means ~13 charges a year, disclosed only in terms
- ⚠ Microdosing tirzepatide sold as 12 months paid in full, with no trial evidence
- ⚠ Promotional urgency and first-month-only discounting
- ⚠ Compounding pharmacy not named; no accreditation or testing published
- ⚠ Two states only
The Bottom Line: A credible two-state clinic practice that gates treatment behind real labs and publishes real prices — with a billing cycle that quietly adds a thirteenth charge every year. If you are in California or Arizona, budget on 13 cycles rather than 12, take the standard-dose program rather than the prepaid microdosing year, and ask which pharmacy compounds your medication. As always, consult your personal physician before starting any new medication program.
Our Verdict: Caution Advised
After our comprehensive investigation, iThriveMD receives a 6.8/10 rating. We've identified some concerns that potential customers should be aware of. We recommend reviewing our top picks before proceeding.
Visit iThriveMDCoreAge Rx
Our highest-rated GLP-1 weight loss program
iThriveMD
Semaglutide from $299, tirzepatide from $399 — billed every 28 days, so about 13 charges per year
Investigation Summary
Share Your Experience
Help others by sharing your experience with iThriveMD
Want to compare options?
View All 195 ProvidersUser Reviews
No ratings yet
Rate your experience
Click a star to rate and add a review
Questions & Discussions
Explore Other Reviews
Compare with other GLP-1 weight loss providers we've investigated
Our Top Picks
Mochi Health
Affordable GLP-1 Access Starting at $99/Month with No Long-Term Commitment
Ro
The Brand-Name GLP-1 Route: FDA-Approved Medications Only, with Insurance Concierge Support
More Provider Reviews
CoreAge Rx
Mochi Health
Remedy Meds
Ready to Get Started with iThriveMD?
Review our findings above and make an informed decision about iThriveMD.
Enter to Win a $1,788 CoreAge Rx Gift Card
Enter for a chance to use it toward eligible CoreAge Rx products and services.
The gift card may be applied toward eligible CoreAge Rx products and services. Prescription products additionally require completing the intake process and evaluation by a licensed healthcare provider, who alone decides eligibility and treatment. Winning does not guarantee that you will qualify for a GLP-1 medication or any other prescription treatment.